FollowTheFilings
Managers
Activity
Compare
Newest
Investment
CONTINEUM THERAPEUTICS INC
Historical 13F holders
CUSIP
21217B100
Type
Equity
Class
CL A
Period
13F filings
2026 Q1
4
2025 Q4
5
2025 Q3
6
2025 Q2
6
2025 Q1
1
2024 Q4
1
2024 Q3
1